Most Recent Articles by Shannon Aymes, MD
Rectal diazepam is currently the only FDA-approved treatment for pediatric status epilepticus.
The migraines were not likely associated with acute altitude syndrome, as the participants were conditioned to living in the low-oxygen environment.
While several studies have demonstrated efficacy in refractory epilepsy, it is still not clear how cannabidiol may have an impact on current epilepsy treatments.
There are a limited number of prediction models that identify patients at risk of major bleeding after stroke or TIA.
Most prescriptions for long-term opioid therapy were written by internal or family medicine physicians.
More Articles by Shannon Aymes, MD
Neurology Advisor Articles
- Updated Ischemic Stroke Guidelines: Expert Takeaways
- Alternative Genetic Risk Variant for Alzheimer Disease Identified
- Advance Directives for Dementia: Honoring Patient Wishes When You Don't Know What They Are
- Ethical Considerations in New Coma Research
- Poor Sleep Associated With Worse PTSD, Chronic Pain in Youth
- Comparing Reference Points for Deep Brain Stimulation Location in Parkinson Disease
- FDA Approves Clinical Decision Support Tool for Stroke
- US Will Produce Radioisotope for MRI, FDA Says
- Cognitive Decline in Men Linked to Low Serum Sodium
- Solanezumab Every 4 Weeks Does Not Significantly Affect Cognitive Decline in Alzheimer Disease